Yüklüyor......
Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma
Etomidate is a very effective drug in severe Cushing's syndrome that is refractory to ketoconazol. Control of the serum cortisol levels in ectopic Cushing's syndrome can be obtained with infusion rates much lower than those used in anesthesia, without respiratory side effects.
Kaydedildi:
| Yayımlandı: | Clin Case Rep |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5930188/ https://ncbi.nlm.nih.gov/pubmed/29744071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1478 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|